Acme Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACME LABS
ACME LABS has three approved drugs.
Drugs and US Patents for Acme Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acme Labs | CLOPIDOGREL BISULFATE | clopidogrel bisulfate | TABLET;ORAL | 078004-001 | May 17, 2012 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Acme Labs | CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 214365-001 | Apr 27, 2023 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Acme Labs | ZOLPIDEM TARTRATE | zolpidem tartrate | TABLET;ORAL | 077214-001 | Apr 23, 2007 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

